BCBS Arkansas Medical Policy Updates – April 2021

Click here to view the Blue Cross Blue Shield Arkansas Medical Policy Updates »

April 2021 BCBS Arkansas Medical Policy Updates:

• Ado-Trastuzumab Emtansine (Trastuzumab-DM1) for Treatment of HER-2 Positive Malignancies
• Biofeedback as a Treatment of Chronic Pain
• Biomarker Test (Vectra™ DA) for Monitoring Disease Activity in Rheumatoid Arthritis
• Biomarker, Serum Human Epididymis Protein 4 (HE4)
• Biomarkers for Liver Disease
• Bone Mineral Density Study
• Brachytherapy, Breast
• Brachytherapy, Prostate, High-Dose Rate Temporary
• Brachytherapy, Prostate, Low-dose Rate
• Chemosensitivity and Chemoresistance Assays, In-Vitro (ChemoFX, Oncotech Extreme Drug Resistance Assay)
• Chromoendoscopy as an Adjunct to Colonoscopy
• Computed Tomography (CT) Perfusion Imaging
• Electrical Stimulation, Deep Brain (e.g. Parkinsonism, Dystonia, Multiple Sclerosis, Post-Traumatic Dyskinesia)
• Elotuzumab (Empliciti™)
• Eteplirsen (Exondys-51)
• Genetic Test: Asthma, HLA-DR and HLA-DQ Genotyping
• Genetic Test: Azothiaprine, 6MP Sensitivity,Genotyping & Phenotyping (TPMT)
• Genetic Test: Chronic Myelogenous Leukemia and Acute Lymphoblastic Leukemia (BCR-ABL)
• Genetic Test: Genotyping for 9p21 Single Nucleotide Polymorphisms to Predict Risk of Cardiovascular Disease or Aneurysm
• Genetic Test: HER2 Testing
• Genetic Test: Microarray-Based Gene Expression Testing for Cancers of Unknown Primary
• Genetic Test: PathFinderTG® Molecular Testing
• Genetic Test: Uveal Melanoma, Gene Expression Profile To Predict Risk Of Metastasis
• Givosiran (GIVLAARI®)
• Infertility Services
• Injection, Clostridial Collagenase for Fibroproliferative Disorders
• Intensity Modulated Radiation Therapy (IMRT)
• Intravitreal Implant, Dexamethasone (Ozurdex)
• Isatuximab-irfc (Sarclisa®)
• Myocardial Strain Imaging
• Nab-Paclitaxel (Abraxane™)
• Needle Arthroscopy
• Omalizumab (Xolair)
• PCSK9 Inhibitors (Evolocumab) (Alirocumab)
• Pegloticase (Krystexxa®)
• Pembrolizumab (KEYTRUDA®)
• Periurethral Bulking Agents for the Treatment of Urinary and Fecal Incontinence
• PET or PET/CT for Hodgkin’s Lymphoma
• PET or PET/CT for Soft Tissue Sarcoma, including Gastrointestinal Stromal Tumor (GIST)
• PET Scans (Positron Emission Tomography)
• PET Scans (Positron Emission Tomography)
• PET Scans (Positron Emission Tomography)
• PET Scans (Positron Emission Tomography)
• Pharmacy: Lutetium Lu 177 Dotatate (Lutathera®)
• Powered Exoskeleton for Ambulation in Patients with Lower Limb Disabilities
• Preventive Services for Non-Grandfathered (PPACA) Plans: Chlamydial Infection Screening in Women & Adolescents
• Preventive Services For Non-Grandfathered (Ppaca) Plans: Depression Screening, Adults
• Preventive Services for Non-Grandfathered (PPACA) Plans: Gestational Diabetes Screening
• PREVENTIVE SERVICES FOR NON-GRANDFATHERED (PPACA) PLANS: GONORRHEA SCREENING IN WOMEN & ADOLESCENTS
• Preventive Services for Non-Grandfathered (PPACA) Plans: Human Immunodeficiency Virus (HIV) Counseling & Screening
• Proteomics, Predict Response to Chemotherapy (VeriStrat®)
• Pulmonary Rehabilitation
• Self-Administered Medication
• Surgery for Morbid Obesity
• Surgical Interruption of Pelvic Nerve Pathways for Primary and Secondary Dysmenorrhea
• Teprotumumab-trbw (TEPEZZA™)
• Transplant, Allogeneic Islet Cell or Pancreas for Diabetes Mellitus
• Tumor Markers, Urinary Bladder Cancer
• Ultrasound in Maternity Care: 1st Trimester Detection of Down Syndrome using Fetal US Assessment of Nuchal Translucency & Maternal Serum Assessment
• Viscosupplementation for the Treatment of Osteoarthritis of the Hip, Knee, and All Other Joints

Click here to view the Blue Cross Blue Shield Arkansas Medical Policy Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.